CN1259908C - 最优化水解的脂质乳剂及其用途 - Google Patents

最优化水解的脂质乳剂及其用途 Download PDF

Info

Publication number
CN1259908C
CN1259908C CNB961986034A CN96198603A CN1259908C CN 1259908 C CN1259908 C CN 1259908C CN B961986034 A CNB961986034 A CN B961986034A CN 96198603 A CN96198603 A CN 96198603A CN 1259908 C CN1259908 C CN 1259908C
Authority
CN
China
Prior art keywords
fish oil
oil
lipid
fish
emulsion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNB961986034A
Other languages
English (en)
Chinese (zh)
Other versions
CN1202823A (zh
Inventor
杰曼·普彻尔
马尔科·朱津格
约尔格·内恩
伊冯·A·卡彭铁尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
B Brown Melsongen Co ltd
Original Assignee
B Brown Melsongen Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7778601&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN1259908(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by B Brown Melsongen Co ltd filed Critical B Brown Melsongen Co ltd
Publication of CN1202823A publication Critical patent/CN1202823A/zh
Application granted granted Critical
Publication of CN1259908C publication Critical patent/CN1259908C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286—Carthamus (distaff thistle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Diabetes (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CNB961986034A 1995-11-28 1996-11-23 最优化水解的脂质乳剂及其用途 Expired - Lifetime CN1259908C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19544310.1 1995-11-28
DE19544310 1995-11-28

Publications (2)

Publication Number Publication Date
CN1202823A CN1202823A (zh) 1998-12-23
CN1259908C true CN1259908C (zh) 2006-06-21

Family

ID=7778601

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB961986034A Expired - Lifetime CN1259908C (zh) 1995-11-28 1996-11-23 最优化水解的脂质乳剂及其用途

Country Status (15)

Country Link
US (1) US6008248A (enExample)
EP (1) EP0863754B2 (enExample)
JP (1) JP4165904B2 (enExample)
CN (1) CN1259908C (enExample)
AT (1) ATE230262T1 (enExample)
AU (1) AU701736B2 (enExample)
BR (1) BR9611826A (enExample)
CA (1) CA2236422C (enExample)
CZ (1) CZ161898A3 (enExample)
DE (2) DE69625616T3 (enExample)
ES (1) ES2189891T5 (enExample)
MX (1) MX9804127A (enExample)
NZ (1) NZ322927A (enExample)
PL (1) PL186618B1 (enExample)
WO (1) WO1997019683A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1090636A1 (en) * 1999-09-13 2001-04-11 Société des Produits Nestlé S.A. High lipid diet
US6946488B2 (en) * 2000-05-01 2005-09-20 The Iams Company Pet food composition for reducing inflammatory response in cats
EP1539104A4 (en) * 2000-12-29 2005-06-15 Univ Columbia USE OF IV EMULSIONS OF DIFFERENT TRIGLYCERIDE COMPOSITION, PARTICLE SIZE AND APOLIPOPROTEIN E FOR TARGETED TISSUE DELIVERY OF HYDROPHOBIC COMPOUNDS
EP1900364B1 (en) * 2001-04-18 2013-09-25 ProMetic BioSciences Inc. Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
EP1279400A1 (en) * 2001-07-25 2003-01-29 Target Hit sa Modifying the fatty acid composition of cell membranes of organs and tissues
US20030032674A1 (en) * 2001-08-13 2003-02-13 Hwang Daniel H. Use of unsaturated fatty acids to treat severe inflammatory diseases
ITMI20012384A1 (it) * 2001-11-12 2003-05-12 Quatex Nv Uso di acidi grassi poliinsaturi per la prevenzione primaria di eventi cardiovascolari maggiori
AU2002350353A1 (en) * 2001-12-27 2003-07-15 Genesis Group Inc. Seal oil based lipid emulsions and uses thereof
CA2496923A1 (en) * 2002-08-29 2004-03-11 University Of Massachusetts Utilization of emulsion interface engineering to produce oxidatively stable lipid delivery systems
US7323206B1 (en) 2003-03-04 2008-01-29 B. Braun Medical Inc. Reagents and methods for all-in-one total parenteral nutrition for neonates and infants
US8241672B2 (en) * 2009-03-11 2012-08-14 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US20110071090A1 (en) * 2009-03-11 2011-03-24 Stable Solutions Llc Method of mitigating adverse drug events using omega-3-fatty acids as a parenteral therapeutic drug vehicle
US9034389B2 (en) 2009-03-11 2015-05-19 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US8993625B2 (en) 2009-03-11 2015-03-31 Stable Solutions Llc Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle
EP2560633B8 (en) 2010-04-23 2020-08-12 The Government of the United States, as represented by The Secretary of the Army Intravenous omega-3 fatty acid compositions & method of use
CN106241871A (zh) * 2016-07-15 2016-12-21 攀钢集团攀枝花钢铁研究院有限公司 高浓度钒液酸性铵盐沉钒方法
CN117918525A (zh) 2017-08-10 2024-04-26 儿童医疗中心有限公司 与包含鱼油和/或ω-3脂肪酸的乳剂有关的方法和组合物
CN108498562B (zh) * 2018-04-08 2021-03-16 北京壹诺药业有限公司 具有抗疲劳抗肿瘤增强免疫的油脂乳状液及其应用
US20220040141A1 (en) * 2018-10-01 2022-02-10 Blue Harvest, Llc Ultrapure phenol compositions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59172416A (ja) * 1983-03-18 1984-09-29 Terumo Corp 脂肪輸液
DE3721137A1 (de) * 1987-06-26 1989-01-05 Dietl Hans Fettemulsion zur intravenoesen anwendung
DE3722540A1 (de) * 1987-07-08 1989-01-19 Fresenius Ag Fettemulsion, verfahren zu ihrer herstellung und ihre verwendung
FR2618332B1 (fr) * 1987-07-23 1990-04-27 Synthelabo Emulsion lipidique destinee a la nutrition parenterale ou enterale
US5034415A (en) * 1987-08-07 1991-07-23 Century Laboratories, Inc. Treatment of diabetes mellitus
DE3734147C2 (de) * 1987-10-09 1998-10-29 Braun Melsungen Ag Isotone omega-3-fettsäurenhaltige Fettemulsion und ihre Verwendung
US5089268A (en) * 1990-05-02 1992-02-18 Katz David P Egg phosphatide lipid emulsions altered for a specific therapeutic fatty acid composition
US5470839A (en) * 1993-04-22 1995-11-28 Clintec Nutrition Company Enteral diet and method for providing nutrition to a diabetic
US5444054A (en) * 1994-04-01 1995-08-22 Abbott Labatories Method of treating ulcerative colitis
US5574065A (en) † 1994-04-21 1996-11-12 Clintec Nutrition Co. Method and composition for normalizing injury response

Also Published As

Publication number Publication date
AU701736B2 (en) 1999-02-04
ES2189891T3 (es) 2003-07-16
PL326929A1 (en) 1998-11-09
ATE230262T1 (de) 2003-01-15
DE69625616T2 (de) 2003-11-06
EP0863754B2 (en) 2009-12-30
JP4165904B2 (ja) 2008-10-15
BR9611826A (pt) 1999-07-13
DE69625616D1 (de) 2003-02-06
DE69625616T3 (de) 2010-07-08
NZ322927A (en) 1999-06-29
EP0863754B1 (en) 2003-01-02
EP0863754A1 (en) 1998-09-16
CN1202823A (zh) 1998-12-23
CZ161898A3 (cs) 1998-11-11
US6008248A (en) 1999-12-28
CA2236422C (en) 2002-11-19
AU7697296A (en) 1997-06-19
PL186618B1 (pl) 2004-02-27
MX9804127A (es) 1998-12-31
DE19648566A1 (de) 1997-06-05
CA2236422A1 (en) 1997-06-05
JP2000500769A (ja) 2000-01-25
ES2189891T5 (es) 2010-04-27
WO1997019683A1 (en) 1997-06-05

Similar Documents

Publication Publication Date Title
CN1267085C (zh) 修改器官和组织细胞膜的脂肪酸组合物
CN1259908C (zh) 最优化水解的脂质乳剂及其用途
US8536232B2 (en) Omega-3 diglyceride emulsions
CN1200701C (zh) 降低坏死性小肠结肠炎发生率的组合物
JP2722229B2 (ja) オメガ‐３・中間鎖トリグリセリド混合物を利用する代替食物
EP0216419B1 (en) Nutritional fat suitable for enteral and parenteral products
KR101503970B1 (ko) 오메가-3 풍부화된 비경구 영양 수중-어유 에멀전
WO2008143642A2 (en) Methods of treating and preventing ocular neovascularization with omega-3 polyunsaturated fatty acids
TWI749451B (zh) 包含ω脂肪酸的醫藥組合物及包含彼之輸液製劑
Driscoll Pharmaceutical and clinical aspects of lipid injectable emulsions
US20160051506A1 (en) Fat Emulsion for Artificially Feeding Seriously Ill Intensive Care Patients
CN1191832C (zh) 血管生成促进剂
JP3132085B2 (ja) 脂肪乳剤
HUP9903426A2 (hu) Optimalizált hidrolízisű lipid emulziók és ezek gyógyszerként történő alkalmazása
CARPENTIER approximately 100 zyxwvutsrqponm

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CX01 Expiry of patent term

Granted publication date: 20060621

EXPY Termination of patent right or utility model